Emerging antibiotics at risk of resistance before clinical use

Researchers from the HUN-REN Biological Research Centre, Szeged (Hungary), have made a concerning discovery about the future of antibiotics.

Why Alzheimer’s Drug Approval Delay? $3 Billion in DMD Gene Therapy; ADHD Prevalence

Why is donanemab, an investigational anti-amyloid agent for early Alzheimer’s disease, facing an approval delay? (The Guardian) Early use of erenumab (Aimovig) showed sustained efficacy

March 27, 2024

23andMe considers sale as cash runs low

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: 23andMe said Tuesday it is

January 30, 2025

Study sheds new light on how CVD is associated with hypertensive disorders of pregnancy

UiB-research sheds light on how CVD is associated with hypertensive disorders of pregnancy – but not for everyone.

March 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.